脂質調節薬の世界市場見通し2022年-2028年

◆英語タイトル:Lipid-regulating Drugs Market, Global Outlook and Forecast 2022-2028

Market Monitor Globalが発行した調査報告書(MMG22NV12660)◆商品コード:MMG22NV12660
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2022年11月
◆ページ数:66
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥625,300見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥721,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の脂質調節薬市場規模と予測を収録しています。・世界の脂質調節薬市場:売上、2017年-2022年、2023年-2028年
・世界の脂質調節薬市場:販売量、2017年-2022年、2023年-2028年
・世界のトップ5企業、2021年

世界の脂質調節薬市場は2021年に000Mドルと評価され、予測期間中に000%のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「スタチン」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。

脂質調節薬のグローバル主要企業は、AbbVie、 Amgen、 Andrx Corporation、 AstraZeneca、 Bristol-Myers Squibb、 Merck、 Novartis、 Pfizer、 Tevaなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、脂質調節薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の脂質調節薬市場:タイプ別、2017年-2022年、2023年-2028年
世界の脂質調節薬市場:タイプ別市場シェア、2021年
・スタチン、非スタチン

世界の脂質調節薬市場:用途別、2017年-2022年、2023年-2028年
世界の脂質調節薬市場:用途別市場シェア、2021年
・小売薬局、病院薬局、オンライン薬局

世界の脂質調節薬市場:地域・国別、2017年-2022年、2023年-2028年
世界の脂質調節薬市場:地域別市場シェア、2021年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における脂質調節薬のグローバル売上、2017年-2022年
・主要企業における脂質調節薬のグローバル売上シェア、2021年
・主要企業における脂質調節薬のグローバル販売量、2017年-2022年
・主要企業における脂質調節薬のグローバル販売量シェア、2021年

さらに、当レポートは主要企業のプロファイルを提示します。
AbbVie、 Amgen、 Andrx Corporation、 AstraZeneca、 Bristol-Myers Squibb、 Merck、 Novartis、 Pfizer、 Teva

*************************************************************

・調査・分析レポートの概要
脂質調節薬市場の定義
市場セグメント
世界の脂質調節薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の脂質調節薬市場規模
世界の脂質調節薬市場規模:2021年 VS 2028年
世界の脂質調節薬市場規模と予測 2017年-2028年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの脂質調節薬の売上
グローバルトップ3およびトップ5企業、2021年売上ベース
グローバル企業の脂質調節薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:スタチン、非スタチン
脂質調節薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:小売薬局、病院薬局、オンライン薬局
脂質調節薬の用途別グローバル売上・予測

・地域別市場分析
地域別脂質調節薬市場規模 2021年と2028年
地域別脂質調節薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
AbbVie、 Amgen、 Andrx Corporation、 AstraZeneca、 Bristol-Myers Squibb、 Merck、 Novartis、 Pfizer、 Teva
...

Lipid-regulating drugs are used to treat dyslipidemias, cardiovascular problems, osteoporosis, and post-menopause complications.
This report contains market size and forecasts of Lipid-regulating Drugs in Global, including the following market information:
Global Lipid-regulating Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Lipid-regulating Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Statins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lipid-regulating Drugs include AbbVie, Amgen, Andrx Corporation, AstraZeneca, Bristol-Myers Squibb, Merck, Novartis, Pfizer and Teva. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lipid-regulating Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lipid-regulating Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lipid-regulating Drugs Market Segment Percentages, by Type, 2021 (%)
Statins
Non-statins
Global Lipid-regulating Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lipid-regulating Drugs Market Segment Percentages, by Application, 2021 (%)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global Lipid-regulating Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lipid-regulating Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lipid-regulating Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Lipid-regulating Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Andrx Corporation
AstraZeneca
Bristol-Myers Squibb
Merck
Novartis
Pfizer
Teva

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Lipid-regulating Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lipid-regulating Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lipid-regulating Drugs Overall Market Size
2.1 Global Lipid-regulating Drugs Market Size: 2021 VS 2028
2.2 Global Lipid-regulating Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lipid-regulating Drugs Players in Global Market
3.2 Top Global Lipid-regulating Drugs Companies Ranked by Revenue
3.3 Global Lipid-regulating Drugs Revenue by Companies
3.4 Top 3 and Top 5 Lipid-regulating Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lipid-regulating Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lipid-regulating Drugs Players in Global Market
3.6.1 List of Global Tier 1 Lipid-regulating Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Lipid-regulating Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Lipid-regulating Drugs Market Size Markets, 2021 & 2028
4.1.2 Statins
4.1.3 Non-statins
4.2 By Type – Global Lipid-regulating Drugs Revenue & Forecasts
4.2.1 By Type – Global Lipid-regulating Drugs Revenue, 2017-2022
4.2.2 By Type – Global Lipid-regulating Drugs Revenue, 2023-2028
4.2.3 By Type – Global Lipid-regulating Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Lipid-regulating Drugs Market Size, 2021 & 2028
5.1.2 Retail Pharmacies
5.1.3 Hospital Pharmacies
5.1.4 Online Pharmacies
5.2 By Application – Global Lipid-regulating Drugs Revenue & Forecasts
5.2.1 By Application – Global Lipid-regulating Drugs Revenue, 2017-2022
5.2.2 By Application – Global Lipid-regulating Drugs Revenue, 2023-2028
5.2.3 By Application – Global Lipid-regulating Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Lipid-regulating Drugs Market Size, 2021 & 2028
6.2 By Region – Global Lipid-regulating Drugs Revenue & Forecasts
6.2.1 By Region – Global Lipid-regulating Drugs Revenue, 2017-2022
6.2.2 By Region – Global Lipid-regulating Drugs Revenue, 2023-2028
6.2.3 By Region – Global Lipid-regulating Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Lipid-regulating Drugs Revenue, 2017-2028
6.3.2 US Lipid-regulating Drugs Market Size, 2017-2028
6.3.3 Canada Lipid-regulating Drugs Market Size, 2017-2028
6.3.4 Mexico Lipid-regulating Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Lipid-regulating Drugs Revenue, 2017-2028
6.4.2 Germany Lipid-regulating Drugs Market Size, 2017-2028
6.4.3 France Lipid-regulating Drugs Market Size, 2017-2028
6.4.4 U.K. Lipid-regulating Drugs Market Size, 2017-2028
6.4.5 Italy Lipid-regulating Drugs Market Size, 2017-2028
6.4.6 Russia Lipid-regulating Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Lipid-regulating Drugs Market Size, 2017-2028
6.4.8 Benelux Lipid-regulating Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Lipid-regulating Drugs Revenue, 2017-2028
6.5.2 China Lipid-regulating Drugs Market Size, 2017-2028
6.5.3 Japan Lipid-regulating Drugs Market Size, 2017-2028
6.5.4 South Korea Lipid-regulating Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Lipid-regulating Drugs Market Size, 2017-2028
6.5.6 India Lipid-regulating Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Lipid-regulating Drugs Revenue, 2017-2028
6.6.2 Brazil Lipid-regulating Drugs Market Size, 2017-2028
6.6.3 Argentina Lipid-regulating Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Lipid-regulating Drugs Revenue, 2017-2028
6.7.2 Turkey Lipid-regulating Drugs Market Size, 2017-2028
6.7.3 Israel Lipid-regulating Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Lipid-regulating Drugs Market Size, 2017-2028
6.7.5 UAE Lipid-regulating Drugs Market Size, 2017-2028
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Lipid-regulating Drugs Major Product Offerings
7.1.4 AbbVie Lipid-regulating Drugs Revenue in Global Market (2017-2022)
7.1.5 AbbVie Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Lipid-regulating Drugs Major Product Offerings
7.2.4 Amgen Lipid-regulating Drugs Revenue in Global Market (2017-2022)
7.2.5 Amgen Key News
7.3 Andrx Corporation
7.3.1 Andrx Corporation Corporate Summary
7.3.2 Andrx Corporation Business Overview
7.3.3 Andrx Corporation Lipid-regulating Drugs Major Product Offerings
7.3.4 Andrx Corporation Lipid-regulating Drugs Revenue in Global Market (2017-2022)
7.3.5 Andrx Corporation Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Lipid-regulating Drugs Major Product Offerings
7.4.4 AstraZeneca Lipid-regulating Drugs Revenue in Global Market (2017-2022)
7.4.5 AstraZeneca Key News
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Corporate Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Lipid-regulating Drugs Major Product Offerings
7.5.4 Bristol-Myers Squibb Lipid-regulating Drugs Revenue in Global Market (2017-2022)
7.5.5 Bristol-Myers Squibb Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Lipid-regulating Drugs Major Product Offerings
7.6.4 Merck Lipid-regulating Drugs Revenue in Global Market (2017-2022)
7.6.5 Merck Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Lipid-regulating Drugs Major Product Offerings
7.7.4 Novartis Lipid-regulating Drugs Revenue in Global Market (2017-2022)
7.7.5 Novartis Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Lipid-regulating Drugs Major Product Offerings
7.8.4 Pfizer Lipid-regulating Drugs Revenue in Global Market (2017-2022)
7.8.5 Pfizer Key News
7.9 Teva
7.9.1 Teva Corporate Summary
7.9.2 Teva Business Overview
7.9.3 Teva Lipid-regulating Drugs Major Product Offerings
7.9.4 Teva Lipid-regulating Drugs Revenue in Global Market (2017-2022)
7.9.5 Teva Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Lipid-regulating Drugs Market Opportunities & Trends in Global Market
Table 2. Lipid-regulating Drugs Market Drivers in Global Market
Table 3. Lipid-regulating Drugs Market Restraints in Global Market
Table 4. Key Players of Lipid-regulating Drugs in Global Market
Table 5. Top Lipid-regulating Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lipid-regulating Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lipid-regulating Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lipid-regulating Drugs Product Type
Table 9. List of Global Tier 1 Lipid-regulating Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lipid-regulating Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lipid-regulating Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lipid-regulating Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lipid-regulating Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lipid-regulating Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lipid-regulating Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lipid-regulating Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lipid-regulating Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lipid-regulating Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lipid-regulating Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lipid-regulating Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lipid-regulating Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lipid-regulating Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lipid-regulating Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lipid-regulating Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Lipid-regulating Drugs Product Offerings
Table 32. AbbVie Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Lipid-regulating Drugs Product Offerings
Table 35. Amgen Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Andrx Corporation Corporate Summary
Table 37. Andrx Corporation Lipid-regulating Drugs Product Offerings
Table 38. Andrx Corporation Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Lipid-regulating Drugs Product Offerings
Table 41. AstraZeneca Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Bristol-Myers Squibb Corporate Summary
Table 43. Bristol-Myers Squibb Lipid-regulating Drugs Product Offerings
Table 44. Bristol-Myers Squibb Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Lipid-regulating Drugs Product Offerings
Table 47. Merck Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Lipid-regulating Drugs Product Offerings
Table 50. Novartis Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Lipid-regulating Drugs Product Offerings
Table 53. Pfizer Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Teva Corporate Summary
Table 55. Teva Lipid-regulating Drugs Product Offerings
Table 56. Teva Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Lipid-regulating Drugs Segment by Type in 2021
Figure 2. Lipid-regulating Drugs Segment by Application in 2021
Figure 3. Global Lipid-regulating Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lipid-regulating Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lipid-regulating Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lipid-regulating Drugs Revenue in 2021
Figure 8. By Type - Global Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 12. US Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 24. China Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Andrx Corporation Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bristol-Myers Squibb Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 脂質調節薬の世界市場見通し2022年-2028年(Lipid-regulating Drugs Market, Global Outlook and Forecast 2022-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆